|
|
Volumn 187, Issue 11, 2011, Pages
|
|
Letter to the Editor on: A. Siegmann et al. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival. Results of a retrospective study. In: Strahlenther Onkol 2011;187:467-72 (No. 8) (DOI 10.1007/s00066-011-2229-3). P. Ghadjar, D. Zwahlen, D.M. Aebersold: Selection bias is not a good reason for
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
BLOOD;
HUMAN;
MALE;
NOTE;
PROSTATE TUMOR;
PROSTATECTOMY;
HUMANS;
MALE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84857077066
PISSN: None
EISSN: 1439099X
Source Type: Journal
DOI: 10.1007/s00066-011-9229-1 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
